ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.

Jacksonville, FL, May 03, 2009 --(PR.com)-- The articles governing the amendment to change the company name were officially received in the offices of ENCO from the state of Florida on April 30, 2009. “We are very excited about the name change as it more accurately reflects our sole focus on the pharmaceutical industry”, said Rick Camp, President of ENCO Pharmaceutical Development, Inc. “We have worked hard over the past 5 years to develop a very positive reputation with our customers within the pharmaceutical and medical device industries and we believe that this change in name will make it easier for new customers to understand our service offerings”, Camp said.

The name change will be evident immediately on all ENCO Analytix, Inc. corporate documents, signage and references. “ENCO Pharmaceutical Development, Inc. is a better descriptor of the services that our company offers” said, Keith Hurley, Vice-President of Sales and Marketing. “We are a dynamic and growing company offering a unique service approach to the pharmaceutical outsourcing industry”, Hurley said. “It’s part of the marketing plan, we want to make sure those companies that are in search of an outsourcing partner to handle their analytical development needs, know that we are here to work with them”, said Hurley.

For additional information on the name change of ENCO Analytix, Inc. to ENCO Pharmaceutical Development, Inc., please contact Keith Hurley, Vice-President of Sales and Marketing at 336.541.3270

About ENCO Pharmaceutical Development, Inc.
ENCO Pharmaceutical Development, Inc. provides technical outsourcing assistance to the pharmaceutical industry, including analytical product development with services that range from raw materials testing to full Phase III stability studies following cGMP standards. The company also provides comprehensive testing on medical devices. ENCO is FDA registered, an ISO accredited analytical laboratory and holds registration with the DEA to handle the development of controlled drug substance for pharmaceutical use. ENCO Pharmaceutical Development, Inc. operates two locations – the corporate headquarters at 4810 Executive Park Ct., Suite 110, Jacksonville, FL and a second location at 102-E Woodwinds Industrial Ct, Cary, NC 27511

###